GLP-1 Receptor Agonist Zepbound Approved as First Drug for Obstructive Sleep Apnea in Individuals with Obesity
MONDAY, Dec. 23, 2024 -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.
In a news release published Dec. 20, the FDA...